Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
3,020
Total Value
$77,096.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 5, 2026 | Sale | 3,020 | $25.53 | $77,096.67 | 91,206 | Direct | โ | View Details |